Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2004 February;95(1) > Minerva Medica 2004 February;95(1):11-24

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA MEDICA

A Journal on Internal Medicine


Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,236


eTOC

 

REVIEWS  


Minerva Medica 2004 February;95(1):11-24

language: English

Ribozymes as antiviral agents

Bartolomé J., Castillo I., Carreño V.


PDF  


Ribozymes are RNA molecules with cleavage activity that can be engineered to specifically target a given RNA molecule. The hammerhead, hairpin and hepatitis d virus ribozymes have been widely studied for their use as therapeutical agents. This review discusses the structure and properties of these ribozymes, along with the advances made in the development of these molecules for their application in the treatment of hepatitis B, hepatitis C and human immunodeficiency virus infections.

top of page

Publication History

Cite this article as

Corresponding author e-mail